SCHEMBL23734263

SCHEMBL23734263

CC(C)Cc1ccccc1NO

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GABRA1 P14867 2/20 0.52
GABRB2 P47870 2/20 0.52
L3MBTL1 Q9Y468 2/20 0.39
NOS3 P29474 1/20 0.36
NOS1 P29475 1/20 0.36
NOS2 P35228 1/20 0.36
MAPT P10636 1/20 0.36
CRHBP P24387 1/20 0.36
RAB9A P51151 1/20 0.36
CRHR2 Q13324 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
MDM4 O15151 1/20 0.36
TP53 P04637 1/20 0.36
CA12 O43570 1/20 0.35
CA2 P00918 1/20 0.35
CA9 Q16790 1/20 0.35
ALDH1A1 P00352 2/20 0.35
POLB P06746 2/20 0.35
KMT2A Q03164 2/20 0.35
MEN1 O00255 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16256389 0.81 GABRA1 (0.48) GABRA1GABRB2L3MBTL1NOS3NOS1
SCHEMBL6504953 0.79 GABRA1 (0.47) GABRA1GABRB2L3MBTL1NOS3NOS1
SCHEMBL19685425 0.78 GABRA1 (0.45) GABRA1GABRB2L3MBTL1MAPTCA12
SCHEMBL11440473 0.77 L3MBTL1 (0.53) GABRA1GABRB2L3MBTL1NOS3NOS1
Hydrogen Peroxide SCHEMBL5685702 0.77 GABRA1 (0.65) GABRA1GABRB2POLBLMNAMAPK1
SCHEMBL840750 0.77 GABRA1 (0.64) GABRA1GABRB2LMNA
SCHEMBL11919003 0.76 L3MBTL1 (0.49) GABRA1GABRB2L3MBTL1NOS3NOS1
SCHEMBL2255093 0.76 ALDH1A1 (0.53) GABRA1GABRB2MAPTALDH1A1POLB
SCHEMBL24673909 0.76 CA12 (0.39) L3MBTL1MAPTMDM4TP53CA12
SCHEMBL24244459 0.75 GABRA1 (0.42) GABRA1GABRB2L3MBTL1NOS3NOS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230160000-A1 SYNTHESIS OF NOVEL DISULFIDE LINKER BASED NUCLEOTIDES AS REVERSIBLE TERMINATORS FOR DNA SEQUENCING BY SYNTHESIS THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) 2023-05-25 US disclosed
US-11085076-B2 Synthesis of novel disulfide linker based nucleotides as reversible terminators for DNA sequencing by synthesis THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) 2021-08-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11085076-B2 Synthesis of novel disulfide linker based nucleotides as reversible terminators for DNA sequencing by synthesis POLRMT, RNGTT, MTR GABRA1 4239/4885GABRB2 4237/4885L3MBTL1 498/4885
US-20230160000-A1 SYNTHESIS OF NOVEL DISULFIDE LINKER BASED NUCLEOTIDES AS REVERSIBLE TERMINATORS FOR DNA SEQUENCING BY SYNTHESIS POLRMT, RNGTT, MTR GABRA1 4239/4885GABRB2 4237/4885L3MBTL1 498/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.